JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moghadasian, M H
Right arrow Articles by Scudamore, C H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moghadasian, M H
Right arrow Articles by Scudamore, C H
Journal of Clinical Pathology 2002;55:859-861
© 2002 Journal of Clinical Pathology


SHORT REPORT

Specificity of the commonly used enzymatic assay for plasma cholesterol determination

M H Moghadasian, J J Frohlich, C H Scudamore

Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, Canada

Correspondence to:
Dr M Moghadasian, Healthy Heart Program, St Paul’s Hospital, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6;
mhmoghad{at}interchange.ubc.ca
ABSTRACT
Aim: To assess the specificity and sensitivity of the commonly used enzymatic colorimetric test for plasma cholesterol determination.

Methods: Interference with an enzymatic method for cholesterol measurement by several non-cholesterol sterols (ß sitosterol, campesterol, stigmasterol, stigmastanol, desmosterol, and lathosterol) was assessed. Some of these compounds are present in plasma at higher than normal concentrations either in rare genetic disorders, such as phytosterolaemia, or after the consumption of phytosterol enriched foods.

Results: The non-cholesterol sterols were detected by the assay in a linear manner. There was no competitive interference in the presence of cholesterol.

Conclusions: This crossreactivity may affect the diagnosis and treatment of non-cholesterol dyslipidaemias, including phytosterolaemia and cerebrotendinous xanthomatosis. Similarly, changes in plasma lipid compositions after the consumption of phytosterol enriched foods cannot be specifically determined by this enzymatic assay. Until a more specific enzymatic assay is developed, alternative methods such as gas chromatography should be used to differentiate between cholesterol and non-cholesterol sterols.


Keywords: cholesterol; non-cholesterol sterols; enzymatic assay

Abbreviations: CHD, coronary heart disease; CTX, cerebrotendinous xanthomatosis




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
S Kidambi and S B Patel
Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis
J. Clin. Pathol., May 1, 2008; 61(5): 588 - 594.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Plosch, J. N. van der Veen, R. Havinga, N. C. A. Huijkman, V. W. Bloks, and F. Kuipers
Abcg5/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice
Am J Physiol Gastrointest Liver Physiol, September 1, 2006; 291(3): G414 - G423.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.